卓正医疗通过港交所聆讯 专注服务中高端医疗服务市场

Core Insights - The article highlights that Zhuozheng Medical is strategically focused on the mid-to-high-end healthcare service market, targeting affluent consumers who prefer personalized medical services. As of 2024, Zhuozheng Medical is the third-largest private mid-to-high-end comprehensive healthcare service provider in China, with a market share of 2.0% [2]. Industry Overview - The mid-to-high-end healthcare service market in China is defined as comprehensive customized services that emphasize patient experience and service quality. This market can be further divided into public and private mid-to-high-end healthcare services. The affluent population is defined as those with an annual disposable income exceeding RMB 200,000 [2]. - By 2024, private mid-to-high-end healthcare institutions are expected to account for approximately 66.5% of the total revenue in the mid-to-high-end healthcare service market in China, which represents about 5.6% of the total revenue in the healthcare service industry [2]. - The total revenue of China's private mid-to-high-end healthcare service market is projected to grow from RMB 193 billion in 2020 to RMB 426.3 billion by 2024, reflecting a compound annual growth rate (CAGR) of 21.9%. The market is expected to continue growing at a CAGR of 14.3% from 2024 to 2029, reaching RMB 831.4 billion by 2029 [2]. Company Overview - Zhuozheng Medical has established a network covering major economically developed cities in China, including Shenzhen, Guangzhou, Beijing, Chengdu, Suzhou, Changsha, Shanghai, Chongqing, Hangzhou, and Wuhan. As of October 28, 2025, the company operates 19 medical service institutions in China, comprising 17 clinics and 2 hospitals [3]. - The company employs a family medical model that integrates both in-person and online healthcare services, offering a range of specialties including pediatrics, dentistry, ophthalmology, dermatology, ENT, surgery, gynecology, and internal medicine, thereby enhancing patient satisfaction and facilitating cross-specialty referrals [4]. Financial Performance - Zhuozheng Medical's revenue has shown a consistent upward trend, with reported revenues of RMB 473.2 million in 2022, RMB 690.4 million in 2023, and RMB 958.6 million in 2024. For the eight months ending August 31, 2025, the company reported revenue of RMB 696.7 million [4][5]. - The company recorded net losses of RMB 222 million in 2022 and RMB 353 million in 2023. However, it achieved a profit of approximately RMB 80.2 million in 2024 and RMB 83.2 million for the eight months ending August 31, 2025 [4][5].